LongeCity interviews

About LongeCity interviews

Pioneers in life extension research & advocacy interviewed by the Longecity.org community forum.

Publisher

LongeCity

Language

en

Explicit

Yes

First episode

9 May 2011

Latest episode

14 Mar 2026

Latest episodes

1 of 112 episodes have a transcript.

1. 

   14 Mar 2026

   2026 Progress at Cyclarity

   Dr Matthew OConnor describes recent positive news from phase one human trials of their drug that removes 7KC from the arteries

2. 

   3 Jun 2025

   Introducing the Rejuvenation Science Institute

   Rejuvenation Science Institute founders discuss their goals to replicate Harold Katcher's mice experiments at Yuvan, advancing rejuvenation research in this interview.

3. 

   6 Apr 2025

   Interview With James Strole

   James Strole discusses AI and biotech, his view on immortality, RAADFest, and personal biohacking.

Inside a recent episode

Interview with Chris Burres of SES Research

Published 25 Mar 2020 · Transcript excerpt

[…] So when you look at how the scientific process is supposed to work, you have a theory. And in this case, the theory was actually that buckyballs would be toxic. So that's that's the theory. And then you do a study. And the result of the study was exactly the opposite of the theory regarding buckyballs. The rats live 90 percent longer. And it's also important to note that they died without tumors, whereas all the control rats died with tumors. And then the next step in the scientific process is you get another lab to redo it like this is basic standard science. So we've got a lot of people. And even to kind of share some of our experience coming off of that 2012 study in 2013, about mid 2013, we started getting phone calls of people saying, hey, how much in a dose? […]

Reach and audience

Public platform figures. Ratings count people who left a rating, not total listeners.

Apple Podcasts (US)

5.0 / 5

3 ratings

Podcast Authority Score: 15 / 100

A composite of feed quality, social presence, YouTube performance and engagement. Read the methodology.

Quality

16

Social presence

0

YouTube

0

Engagement

32